| Absorption |
| Blood-Brain Barrier | BBB- | 0.9660 |
| Human Intestinal Absorption | HIA+ | 0.9934 |
| Caco-2 Permeability | Caco2- | 0.8958 |
| P-glycoprotein Substrate | Substrate | 0.5953 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9036 |
| Non-inhibitor | 0.8465 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8903 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7131 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7897 |
| CYP450 2D6 Substrate | Non-substrate | 0.9116 |
| CYP450 3A4 Substrate | Non-substrate | 0.6928 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7862 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9563 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9638 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9451 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9121 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9516 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7514 |
| Non-inhibitor | 0.7961 |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.9322 |
| Fish Toxicity | Low FHMT | 0.6327 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6421 |
| Honey Bee Toxicity | Low HBT | 0.6051 |
| Biodegradation | Ready biodegradable | 0.6459 |
| Acute Oral Toxicity | II | 0.5282 |
| Carcinogenicity (Three-class) | Non-required | 0.7037 |